New Drug UB-312 Shows Promise in Treating Parkinson's Disease

A new drug, UB-312, is showing promise in relieving symptoms of Parkinson's disease by targeting toxic proteins in the brain. The drug is being tested in phase 1 trials and has shown positive effects on patients' daily movement. The ultimate goal is to develop disease-modifying treatments for Parkinson's.